February 6th 2020 There are many reasons a treatment might not be available for patients, but this one from a recommendation by a UK National Health Service (NHS) watchdog shocked us: the £10,000 cost for the treatment is too high to make available to patients with severe depression that might benefit from it!?!?!? Typically where … Continue reading Ketamine antidepressant spray treatment not available for patients…because of cost?
Tag: NMDA receptor
The animal research behind the new nasal spray depression treatment
Or, our tax dollars at work! Last week, the FDA approved a new drug for treatment-resistant depression (TRD). The nasal spray version of the drug ketamine, called Spravato (esketamine), is a newly-approved, fast-acting drug, available only with a doctor’s prescription, that could help millions. Did you know that a wide range of nonhuman animal research … Continue reading The animal research behind the new nasal spray depression treatment
A Noble cause: Protecting babies brains with Xenon
Back in October I wrote about how animal research has enabled the development of brain cooling as a treatment to reduce brain damage in babies who had suffered oxygen starvation during birth. This is a problem that affects tens of thousands of babies every year, and frequently results in death or long-term disability. Brain cooling … Continue reading A Noble cause: Protecting babies brains with Xenon